Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on July 9, 2007

Hypertension. 2007
Published online before print July 9, 2007, doi: 10.1161/HYPERTENSIONAHA.107.092528
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/3/537    most recent
HYPERTENSIONAHA.107.092528v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grassi, G.
Right arrow Articles by Mancia, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grassi, G.
Right arrow Articles by Mancia, G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Clinical Studies

Submitted on April 16, 2007
Revised on May 4, 2007

Neurogenic Abnormalities in Masked Hypertension

Guido Grassi*; Gino Seravalle; Fosca Quarti Trevano; Raffaella Dell’Oro; GianBattista Bolla; Cesare Cuspidi; Francesca Arenare; and Giuseppe Mancia

From the Clinica Medica (G.G., F.Q.T., R.D., F.A., G.M.), Università Milano-Bicocca, Ospedale S Gerardo, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione (G.G., G.B., G.M.), Milan, Monza, and Pavia, Italy; Centro Ipertensione Arteriosa e Prevenzione Cardiovascolare (C.C.), Policlinico di Monza, Monza, Italy; and the Istituto Auxologico Italiano (G.G., G.S., G.M.), Milan, Italy.

* To whom correspondence should be addressed. E-mail: guido.grassi{at} unimib.it.

Abstract--Patients with hypertension exhibit an increased sympathetic activity. No information exists as to whether this is the case in normotensive individuals in whom there is an increased ambulatory blood pressure, a condition termed "masked" hypertension. We studied 18 middle-aged subjects with masked hypertension in whom we measured muscle sympathetic nerve traffic (peroneal nerve and microneurography) and beat-to-beat arterial blood pressure at rest and during baroreceptor deactivation and activation. Measurements also included anthropometric values and insulin sensitivity (homeostasis model assessment index). Data were compared with those of 20 normotensive subjects, 18 subjects with white-coat hypertension, and 20 patients with "in-office" and "out-of-office" hypertension. All of the individuals were pharmacologically untreated and age-matched with subjects with masked hypertension. Patients with in- and out-of-office and white-coat hypertension displayed resting sympathetic nerve activity values significantly greater than normotensive subjects (75.8±2.5 and 70.8±2.2 versus 45.5±2.0 bursts per 100 heartbeats respectively; P<0.01). This was the case also for masked hypertension (73.5±2.4 bursts per 100 heartbeats; P<0.01), the degree of the sympathetic activation being similar for magnitude to that seen in the other 2 hypertensive conditions. Compared with normotensive subjects, baroreflex-heart rate control was significantly attenuated in all of the hypertensive states, whereas baroreflex-sympathetic control was unaffected. Homeostasis model assessment index was increased in patients with in- and out-of-office and white-coat hypertension, with a further increase in masked hypertension and a direct relation with resting sympathetic nerve traffic (r=0.46; P<0.01). These data provide the first evidence that masked hypertension is characterized by a marked sympathetic overdrive. They further show that the neurogenic alterations are coupled with metabolic and baroreflex abnormalities.


Key words: masked hypertension • sympathetic activity • white-coat hypertension • ambulatory blood pressure monitoring • baroreflex




This article has been cited by other articles:


Home page
Diabetes CareHome page
M. Bursztyn and I. Z. Ben-Dov
White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
Diabetes Care, November 1, 2009; 32(suppl_2): S310 - S313.
[Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi
Assessment of Sympathetic Cardiovascular Drive in Human Hypertension: Achievements and Perspectives
Hypertension, October 1, 2009; 54(4): 690 - 697.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, F. Arenare, D. Spaziani, and G. Mancia
Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction
Hypertension, February 1, 2009; 53(2): 205 - 209.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Zubcevic, H. Waki, C. Diez-Freire, A. Gampel, M. K. Raizada, and J. F.R. Paton
Chronic Blockade of Phosphatidylinositol 3-Kinase in the Nucleus Tractus Solitarii Is Prohypertensive in the Spontaneously Hypertensive Rat
Hypertension, January 1, 2009; 53(1): 97 - 103.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, M. Bombelli, C. Cuspidi, R. Facchetti, G. Bolla, and G. Mancia
Adrenergic, Metabolic, and Reflex Abnormalities in Reverse and Extreme Dipper Hypertensives
Hypertension, November 1, 2008; 52(5): 925 - 931.
[Abstract] [Full Text] [PDF]